Dr. Niekamp [Dennis and Marsha Dammerman Fellow] studies how gene expression programs are regulated in normal and cancer cells. The ability to switch specific genes "on" and "off" is partly encoded by multiprotein complexes competing for access to target DNA sequences in chromatin structures. The relative distribution of these activating or repressive complexes along chromatin regulates gene expression, and a shift in the balance of these complexes is a hallmark of many cancers. Dr. Niekamp aims to determine how chromatin accessibility is achieved by the competition between activating and repressive complexes, and to understand how well-known cancer mutations disrupt the fine-tuned balance.
Damon Runyon Researchers
Meet Our Scientists
Stefan Niekamp, PhD
      Project title:     "Understanding the switch: Competition between chromatin remodeler and polycomb repressive complexes"  
  
      Institution:     Massachusetts General Hospital  
  
      Named Award:     Dennis and Marsha Dammerman Fellow  
  
      Award Program:     Fellow  
  
      Sponsor(s) / Mentor(s):     Robert E. Kingston, PhD  
  
      Cancer Type:     All Cancers  
  
      Research Area:     Biophysics  
   
  





